These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8750720)

  • 41. Endothelin-1 receptor antagonists protect the kidney against the nephrotoxicity induced by cyclosporine-A in normotensive and hypertensive rats.
    Caires A; Fernandes GS; Leme AM; Castino B; Pessoa EA; Fernandes SM; Fonseca CD; Vattimo MF; Schor N; Borges FT
    Braz J Med Biol Res; 2017 Dec; 51(2):e6373. PubMed ID: 29267497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats: renal and hemodynamic effects of endothelin receptor antagonists.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S470-2. PubMed ID: 8587449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of endothelin in the age dependent increase in renal vascular resistance in the rat kidney.
    Greenfeld Z; Engels K; Samsell L; Baylis C
    Mech Ageing Dev; 1998 Mar; 101(1-2):145-52. PubMed ID: 9593320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.
    Nambi P; Pullen M; Wu HL; Lee D; Saunders D; Heys R; Aiyar N; Leber J; Elliott J; Brooks D; Ohlstein E; Ruffolo R
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1567-71. PubMed ID: 8667224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
    McLaughlin GE; Kashimawo LA; Steele BW; Kuluz JW
    Pediatr Crit Care Med; 2003 Jul; 4(3):358-62. PubMed ID: 12831420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal effects of endothelin in anesthetized rabbits.
    Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
    Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
    Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP
    Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
    Warner TD; Allcock GH; Vane JR
    Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist.
    Bagnis C; Deray G; Dubois M; Pirotzky E; Jacquiaud C; Baghos W; Aupetit B; Braquet P; Jacobs C
    Nephrol Dial Transplant; 1996 Mar; 11(3):507-13. PubMed ID: 8671822
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ANG II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction.
    Conger JD; Kim GE; Robinette JB
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F443-9. PubMed ID: 8092258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacology of two novel mixed ETA/ETB receptor antagonists, BQ-928 and 238, in the carotid and pulmonary arteries and the perfused kidney of the rabbit.
    Maurice MC; Gratton JP; D'Orléans-Juste P
    Br J Pharmacol; 1997 Jan; 120(2):319-25. PubMed ID: 9117126
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ET(B) receptor cascade.
    El-Gowelli HM; Helmy MW; Ali RM; El-Mas MM
    Toxicol Appl Pharmacol; 2014 Mar; 275(2):88-95. PubMed ID: 24462674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ETA receptors mediate vasoconstriction, whereas ETB receptors clear endothelin-1 in the splanchnic and renal circulation of healthy men.
    Böhm F; Pernow J; Lindström J; Ahlborg G
    Clin Sci (Lond); 2003 Feb; 104(2):143-51. PubMed ID: 12546636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endothelin receptors mediating vasoconstriction in rat pressurized small arteries.
    Sharifi AM; Schiffrin EL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):934-9. PubMed ID: 8960383
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasoconstrictor effect of endothelin-1 in human skin: role of ETA and ETB receptors.
    Lipa JE; Neligan PC; Perreault TM; Baribeau J; Levine RH; Knowlton RJ; Pang CY
    Am J Physiol; 1999 Feb; 276(2):H359-67. PubMed ID: 9950834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coronary vasoconstriction in vitro in the hearts of polyarthritic rats: effectiveness of in vivo treatment with the endothelin receptor antagonist SB 209670.
    Klemm P; Warner TD; Willis D; Moore AR; Vane JR
    Br J Pharmacol; 1995 Apr; 114(7):1327-8. PubMed ID: 7606336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670.
    Douglas SA; Edwards RM; Elliott JD; Ohlstein EH
    Br J Pharmacol; 1995 Jan; 114(2):405-13. PubMed ID: 7881741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.